Document is current
Any future updates will be listed below
-
Authors
Rajesh, Anand E.
Olvera-Barrios, Abraham https://orcid.org/0000-0002-3305-4465
Warwick, Alasdair N.
Wu, Yue
Stuart, Kelsey V. https://orcid.org/0000-0001-7353-8774
Biradar, Mahantesh I. https://orcid.org/0000-0002-4114-6255
Ung, Chuin Ying
Khawaja, Anthony P. https://orcid.org/0000-0001-6802-8585
Luben, Robert https://orcid.org/0000-0002-5088-6343
Foster, Paul J. https://orcid.org/0000-0002-4755-177X
Cleland, Charles R.
Makupa, William U.
Denniston, Alastair K. https://orcid.org/0000-0001-7849-0087
Burton, Matthew J.
Bastawrous, Andrew
Keane, Pearse A. https://orcid.org/0000-0002-9239-745X
Chia, Mark A.
Turner, Angus W. https://orcid.org/0000-0001-5949-7451
Lee, Cecilia S. https://orcid.org/0000-0003-1994-7213
Tufail, Adnan https://orcid.org/0000-0001-6131-7640
Lee, Aaron Y. https://orcid.org/0000-0002-7452-1648
Egan, Catherine https://orcid.org/0000-0001-5593-1169
,
Allen, Naomi
Aslam, Tariq
Atan, Denize
Balaskas, Konstantinos
Barman, Sarah
Barrett, Jenny
Bishop, Paul
Black, Graeme
Braithwaite, Tasanee
Carare, Roxana
Chakravarthy, Usha
Chan, Michelle
Chua, Sharon
Day, Alexander
Desai, Parul
Dhillon, Baljean
Dick, Andrew
Doney, Alexander
Ennis, Sarah
Gallacher, John
Garway-Heath, David Ted
Gibson, Jane
Guggenheim, Jeremy
Hammond, Chris
Hardcastle, Alison
Harding, Simon
Hogg, Ruth
Hysi, Pirro
Lascaratos, Gerassimos
Littlejohns, Thomas
Lotery, Andrew
Luthert, Phil
MacGillivray, Tom
Mackie, Sarah
Madhusudhan, Savita
McGuinness, Bernadette
McKay, Gareth
McKibbin, Martin
Moore, Tony
Morgan, James
O’Sullivan, Eoin
Oram, Richard
Owen, Chris
Patel, Praveen
Paterson, Euan
Peto, Tunde
Petzold, Axel
Pontikos, Nikolas
Rahi, Jugnoo
Rudnicka, Alicja
Sattar, Naveed
Self, Jay
Sergouniotis, Panagiotis
Sivaprasad, Sobha
Steel, David
Stratton, Irene
Strouthidis, Nicholas
Sudlow, Cathie
Sun, Zihan
Tapp, Robyn
Thomas, Dhanes
Trucco, Emanuele
Viswanathan, Ananth
Vitart, Veronique
Weedon, Mike
Williams, Katie
Williams, Cathy
Woodside, Jayne
Yates, Max
Zheng, Yalin
-
Funding
Funding for this research was provided by:
DH | National Institute for Health Research
UCL | UCL Institute of Ophthalmology, University College London
- License Information
-
More Information
Article History
Received: 29 June 2023
Accepted: 5 December 2024
First Online: 2 January 2025
Competing interests
: A.P.K. has acted as a paid consultant or lecturer to Abbvie, Aerie, Allergan, Google Health, Heidelberg Engineering, Novartis, Reichert, Santen,Thea and Topcon. A.Y.L. reports support from the US Food and Drug Administration, grants from Santen, Carl Zeiss Meditec, and Novartis, personal fees from Genentech, Topcon, and Verana Health, outside of the submitted work; This article does not reflect the opinions of the Food and Drug Administration. A.T. report grants from Bayer and Novartis and personal fees from Abbvie, Allegro, Annexon, Apellis, Bayer, Heidelberg Engineering, Iveric Bio, Kanghong, Novartis, Oxurion, Roche/Genentech, Thea. C.E. reports personal fees from Heidelberg Engineering, Boehringer Ingelheim, and Inozyme pharmaceuticals outside of the submitted work. P.A.K. has acted as a consultant for Retina Consultants of America, Topcon, Roche, Boehringer-Ingleheim, and Bitfount and is an equity owner in Big Picture Medical. He has received speaker fees from Zeiss, Novartis, Gyroscope, Boehringer-Ingleheim, Apellis, Roche, Abbvie, Topcon, and Hakim Group. He has received travel support from Bayer, Topcon, and Roche. He has attended advisory boards for Topcon, Bayer, Boehringer-Ingleheim, RetinAI, and Novartis. P.J.F. has acted as a consultant for Alphasights, GLG, Google Health, Guidepoint, PwC, Santen. A.B. is Founder and CEO of not-for-profit Peek Vision and receives a salary. The remaining authors declare no competing interests.
